Medical Cannabis Market Size, Share & Growth 2035

What Is the Current Size of the Medical Cannabis Market and Why Is It Growing So Fast?

The global medical cannabis market size was valued at USD 15.69 Billion in 2025, driven by the increased legalization of cannabis across the globe. According to Expert Market Research, the market is anticipated to grow at a remarkable CAGR of 24.00% during the forecast period of 2026–2035, achieving a projected value of USD 134.85 Billion by 2035. This explosive growth reflects a fundamental shift in how healthcare systems worldwide are recognizing cannabis as a legitimate therapeutic agent.

Medical cannabis market  also known as medicinal cannabis  refers to the use of the Cannabis sativa plant and its derivatives for the treatment and management of various health conditions, including chronic pain, mental disorders, cancer-related symptoms, and neurological diseases. What was once a stigmatized substance is rapidly becoming a cornerstone of modern alternative medicine, thanks to mounting clinical evidence, evolving regulatory frameworks, and rising patient demand for non-opioid therapies.

Expert Market Research, a leading authority in pharmaceutical and life sciences intelligence, has consistently identified expanding legalization and the therapeutic validation of cannabinoids as the dual engine powering this market's extraordinary growth trajectory.

Medical Cannabis Market Size and Share: Key Figures You Need to Know

Understanding the medical cannabis market size and share requires a look at both its current valuation and segmental distribution. The global market was worth USD 15.69 Billion in 2025, with North America commanding the dominant regional share. According to multiple industry analyses, North America holds approximately 55% of the global market, bolstered by progressive state and federal-level regulation in the United States and Canada's fully legalized medical framework.

Europe accounts for roughly 25% of global share and is witnessing accelerated growth following Germany's landmark legalization reforms in 2024. Meanwhile, Asia Pacific, Latin America, and the Middle East and Africa collectively represent the remaining share but are projected to register the fastest compound growth rates over the forecast period as emerging economies expand their medical cannabis programs.

Medical Cannabis Market at a Glance

How Is the Medical Cannabis Market Segmented? A Breakdown by Product, Application & End User

The medical cannabis market is segmented across multiple dimensions  product type, application, end user, and geography  providing a comprehensive view of where demand is concentrated and where future growth opportunities lie.

By Product Type

The market is divided into Buds/Marijuana Flower and Cannabis Extracts. Cannabis extracts  encompassing oils, tinctures, capsules, and concentrates have emerged as the dominant product category due to their precise dosing capabilities, longer shelf life, and growing physician preference for standardized formulations. Cannabis flower remains widely used, particularly in markets with established dispensary networks.

By Application

Chronic Pain remains the largest application segment, accounting for the majority of medical cannabis prescriptions globally. The segment is driven by the opioid crisis, which has prompted patients and physicians alike to seek safer, less addictive alternatives. Mental Disorders — including anxiety, PTSD, and depression — represent the second-fastest growing application, with several clinical trials demonstrating cannabidiol (CBD) efficacy in mood regulation. Cancer-related treatment, including chemotherapy-induced nausea management, is another major driver, alongside emerging applications categorized under 'Others,' such as epilepsy and multiple sclerosis.

By End User

The Pharmaceutical segment dominates the end-user landscape, reflecting the increasing commercialization of cannabis-based prescription medicines. Research and Development Centres represent a rapidly growing end-user segment, fueled by significant investment from both private companies and academic institutions seeking to unlock new cannabinoid-based therapeutics.

Get a free request sample report:

Medical Cannabis Market: Top Trends Shaping the Industry in 2025 and Beyond

The medical cannabis market is undergoing rapid transformation. Expert Market Research has identified the following critical trends driving the market forward:

• Expanding Global Legalization: The medical cannabis market continues to benefit from progressive policy reforms. As of 2025, over 40 countries have enacted legislation permitting medical cannabis use, with Germany, Thailand, and Australia among the most impactful recent additions.
• Rise of Cannabis-Based Pharmaceuticals: Companies like GW Pharmaceuticals plc. have pioneered FDA-approved cannabis-derived drugs such as Epidiolex, validating the medical cannabis market's integration into mainstream medicine.
• Growth of Cannabis Extracts Over Flower: The medical cannabis market is witnessing a clear shift toward oil-based and extract-based products, with oils and tinctures gaining preference due to consistent potency and ease of administration.
• Surge in Chronic Pain and Mental Health Applications: As opioid dependency remains a global health crisis, the medical cannabis market is seeing unprecedented demand from chronic pain and mental disorder segments.
• Increased R&D Investment and Clinical Trials: Major players in the medical cannabis market, including Aurora Cannabis Inc., Tilray, Inc., and Canopy Growth Corporation, are actively expanding their research pipelines into oncology, neurology, and psychiatry.
• Telehealth and Digital Prescription Platforms: The medical cannabis market is being democratized through telemedicine, enabling patients to access cannabis prescriptions remotely — a trend that accelerated post-pandemic.
• Asia Pacific as the Emerging Growth Frontier: The medical cannabis market in Asia Pacific is expanding rapidly, with countries like India, South Korea, and Japan revisiting cannabis regulations, presenting major untapped opportunities.
• Vertical Integration Among Market Leaders: Leading medical cannabis market players are increasingly pursuing vertical integration — from cultivation to retail — to control quality, reduce costs, and capture more margin along the value chain.

Regional Analysis: Where Is the Medical Cannabis Market Growing the Fastest?

North America continues to dominate the global medical cannabis market, led by the United States and Canada. The U.S. medical cannabis market benefits from over 38 state-level legalizations and growing bipartisan federal support, while Canada's fully regulated national framework has made it a model for global cannabis policy.

Europe is the second-largest region for the medical cannabis market, with Germany's 2024 legalization serving as a catalyst for continent-wide regulatory momentum. The UK, Poland, and the Netherlands are among the fastest-moving European medical cannabis markets.

Asia Pacific represents the most exciting long-term growth opportunity in the medical cannabis market. Australia's Therapeutic Goods Administration (TGA) has approved thousands of medical cannabis prescriptions, India is expanding its Ayurvedic-cannabis research sector, and several Southeast Asian nations are quietly revising their narcotics frameworks.

Latin America and the Middle East and Africa remain nascent but promising, with countries like Colombia, Brazil, and Israel emerging as significant medical cannabis cultivation and export hubs.

Who Are the Key Players in the Medical Cannabis Market?

The medical cannabis market features a diverse competitive landscape, spanning vertically integrated cannabis producers, pharmaceutical companies, and biotech firms. According to Expert Market Research, the following companies are among the most significant players shaping the global medical cannabis market:

Aurora Cannabis Inc. | Canopy Growth Corporation | Cronos Group Inc. | Medical Marijuana, Inc. | OrganiGram Holding Inc. | Terra Tech Corp. | Tikun Olam Ltd. | Tilray, Inc. | VIVO Cannabis Inc. | Medmen Enterprise Inc. | Stenocare | Trulieve | GW Pharmaceuticals plc. | Cannabis Sativa, Inc.

These companies are competing through product innovation, strategic acquisitions, geographic expansion, and research partnerships. GW Pharmaceuticals plc. remains particularly noteworthy for its role in pharmaceutical-grade cannabis drug development, while Aurora Cannabis Inc. and Canopy Growth Corporation continue to dominate the North American medical cannabis supply chain.

Expert Market Research notes that the competitive intensity in the medical cannabis market is rising, with mid-tier players increasingly challenging established incumbents through specialized formulations and niche therapeutic focus areas.

What Are the Key Growth Drivers and Challenges in the Medical Cannabis Market?

The medical cannabis market's phenomenal growth trajectory is underpinned by several interrelated drivers. The global opioid epidemic has created an urgent need for effective, non-addictive pain management solutions, and the medical cannabis market has stepped in to fill that void. An aging global population with higher incidence of chronic conditions further amplifies demand. The growing body of peer-reviewed evidence validating cannabinoid therapeutics has gradually dismantled clinical and regulatory resistance.

However, the medical cannabis market still faces significant headwinds. Regulatory fragmentation across jurisdictions creates compliance burdens that are particularly challenging for international operators. Under international treaties such as the Single Convention on Narcotic Drugs, cannabis remains a controlled substance, limiting cross-border trade. Inconsistent quality standards and the lingering stigma around cannabis use in certain cultures also constrain market penetration in several regions.

Despite these obstacles, Expert Market Research projects that accelerating regulatory harmonization and continued pharmaceutical validation will progressively reduce these barriers, allowing the medical cannabis market to realize its full growth potential by 2035.

FAQs: Medical Cannabis Market

Q1. What is the current size of the medical cannabis market?

The global medical cannabis market size was valued at USD 15.69 Billion in 2025. According to Expert Market Research, the market is forecast to grow at a CAGR of 24.00% between 2026 and 2035, reaching USD 134.85 Billion by 2035, driven by expanding legalization, rising chronic pain incidence, and growing acceptance of cannabis-based pharmaceuticals.

Q2. What factors are driving growth in the medical cannabis market?

Key growth drivers for the medical cannabis market include the global opioid crisis pushing demand for alternative pain therapies, increasing legalization across more than 40 countries, growing clinical research validating cannabis for conditions such as epilepsy, PTSD, and cancer, an aging population with rising chronic disease burden, and intensified R&D investment from pharmaceutical companies and biotech firms alike.

Q3. Which region dominates the global medical cannabis market?

North America currently holds the largest share of the global medical cannabis market, followed by Europe. However, Asia Pacific is projected to register the fastest CAGR during the 2026–2035 forecast period, with Australia, Thailand, and India driving regional expansion.

Q4. Who are the top companies in the medical cannabis market?

Major players in the global medical cannabis market include Aurora Cannabis Inc., Canopy Growth Corporation, Tilray Inc., GW Pharmaceuticals plc., Trulieve, Cronos Group Inc., Tikun Olam Ltd., and OrganiGram Holding Inc., among others.

Q5. What are the main applications of medical cannabis?

Medical cannabis is primarily used for chronic pain management, mental health disorders (including anxiety, PTSD, and depression), cancer-related symptom relief (particularly chemotherapy-induced nausea), epilepsy, and neurological conditions such as multiple sclerosis. 

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

Media Contact

Company Name: Claight Corporation

Contact Person: Deepanshu Choudhary, Business Consultant

Email: sales@expertmarketresearch.com

Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790

Address: 30 North Gould Street, Sheridan, WY 82801, USA

Website: www.expertmarketresearch.com

Author name- Deepanshu Choudhary